Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
Nature Immunology|March 23, 2016
Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse eventsOlga Sobolev, Elisa Binda, Sean O'Farrell, et al.
The Journal of Infection|November 5, 2023
The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in EnglandRachel Lunt, Catherine Quinot, Freja Kirsebom, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 16, 2023
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)Thomas R Fanshawe, Sharon Tonner, Philip J Turner, et al.
The Lancet Regional Health. Europe|April 19, 2021
Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolationHannah Taylor, William Wall, David Ross, et al.
The Journal of Clinical Investigation|November 27, 2008
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansCarmela De Santo, Mariolina Salio, S Hajar Masri, et al.
Vaccine|August 26, 2011
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trialRebecca J Cox, Gabriel Pedersen, Abdullah S Madhun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccineGrazia Galli, Kathy Hancock, Katja Hoschler, et al.
Microbial Genomics|August 17, 2023
Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillanceTom G S Williams, Luke B Snell, Christopher Alder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 30, 2024
Validation of an acute respiratory infection phenotyping algorithm to support robust computerised medical record-based respiratory sentinel surveillance, England, 2023William H Elson, Gavin Jamie, Rashmi Wimalaratna, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2015
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort StudyAndrew C Hayward, Lili Wang, Nilu Goonetilleke, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
Nature Immunology|March 23, 2016
Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse eventsOlga Sobolev, Elisa Binda, Sean O'Farrell, et al.
The Journal of Infection|November 5, 2023
The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in EnglandRachel Lunt, Catherine Quinot, Freja Kirsebom, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 16, 2023
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)Thomas R Fanshawe, Sharon Tonner, Philip J Turner, et al.
The Lancet Regional Health. Europe|April 19, 2021
Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolationHannah Taylor, William Wall, David Ross, et al.
The Journal of Clinical Investigation|November 27, 2008
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansCarmela De Santo, Mariolina Salio, S Hajar Masri, et al.
Vaccine|August 26, 2011
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trialRebecca J Cox, Gabriel Pedersen, Abdullah S Madhun, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccineGrazia Galli, Kathy Hancock, Katja Hoschler, et al.
Microbial Genomics|August 17, 2023
Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillanceTom G S Williams, Luke B Snell, Christopher Alder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 30, 2024
Validation of an acute respiratory infection phenotyping algorithm to support robust computerised medical record-based respiratory sentinel surveillance, England, 2023William H Elson, Gavin Jamie, Rashmi Wimalaratna, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2015
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort StudyAndrew C Hayward, Lili Wang, Nilu Goonetilleke, et al.
Pageof 27